Drug intelligence / Profile preview

EB-PA

Development stage: Preclinical
Lead developer: Vedic Lifesciences
Administration: Oral

Overview

EB-PA is a dietary supplement developed by Vedic Lifesciences Pvt. Ltd. It is currently undergoing a placebo-controlled, single-blind sequential study to evaluate its efficacy in increasing muscle mass and strength in occasional gym-goers. The study involves 30 participants aged between 18 and 35 years, with a treatment duration of 60 days, where participants take one capsule daily after breakfast.

Beyond the preview

Go deeper on EB-PA.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on EB-PA.

Explore the full profile